Written answers
Tuesday, 25 February 2014
Department of Health
Medicinal Products Licensing
Seán Ó Fearghaíl (Kildare South, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
634. To ask the Minister for Health the total number of serious adverse reactions to Lariam, using the strict medical definition of "serious", reported to the Irish Medicines Board, where the symptoms have persisted for less than a year, where symptoms have persisted for more than one year but less than three, where symptoms have persisted for more than three years but have now resolved, and where symptoms have persisted for more than three years, have still not resolved and where a serious adverse reaction was reported but the IMB has no follow-up data on whether these symptoms persist or have resolved; and if he will make a statement on the matter. [8896/14]
James Reilly (Dublin North, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The Irish Medicines Board is the statutory body responsible for the authorisation of marketing permission for pharmaceutical products and the monitoring of possible adverse reactions to such products. Therefore, I have asked the IMB to reply directly to the Deputy in this regard.
No comments